OverviewSuggest Edit

Based on advances in chemical biology and network science, network pharmacology is a distinctive new approach to drug discovery. It involves application of network analysis to determine the set of proteins most critical in any disease, and then chemical biology to identify molecules capable of targeting that set of proteins. By addressing the true complexity of disease and by seeking to harness the ability of drugs to influence many different proteins, network pharmacology differs from conventional drug discovery approaches, which have generally been based on highly specific targeting of a single protein. Network pharmacology has the potential to provide new treatments for complex diseases where conventional approaches have failed to deliver satisfactory therapies.

HQLong Hanborough, GB


E-Therapeutics is headquartered in
Long Hanborough, United Kingdom

Location Map

Latest Updates

Employees (est.) (Jan 2018)20(-16%)
Revenue (FY, 2019)£44 K
Share Price (Sept 2020)£0.1 (-3%)
Cybersecurity ratingAMore

Key People/Management at E-Therapeutics

Iain Ross

Iain Ross

Non-Exec Chairman
Jonny Wray

Jonny Wray

Chief Technology Officer
Ali Mortazavi

Ali Mortazavi

Executive Chairman
Colin Stubberfield

Colin Stubberfield

Chief Research Officer
Alan Whitmore

Alan Whitmore

Chief Scientific Officer
Laura Roca-Alonso

Laura Roca-Alonso

Chief Business Officer
Show more

E-Therapeutics Office Locations

E-Therapeutics has offices in Long Hanborough and Newcastle upon Tyne
Long Hanborough, GB (HQ)
Blenheim Office Park, 17 Fenlock Rd
Newcastle upon Tyne, GB
11 Waterloo St
Show all (2)

E-Therapeutics Financials and Metrics

E-Therapeutics Revenue

E-Therapeutics's revenue was reported to be £44 k in FY, 2019

Revenue (FY, 2019)


Net income (FY, 2019)


EBITDA (FY, 2019)


EBIT (FY, 2019)


Market capitalization (21-Sept-2020)


Closing stock price (21-Sept-2020)


Cash (31-Jan-2019)

E-Therapeutics's current market capitalization is £59.9 m.
GBPFY, 2017FY, 2018FY, 2019



Operating expense total




EBITDA margin, %

GBPFY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019



Accounts Receivable


Current Assets



GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income


Cash From Operating Activities


Cash From Financing Activities


Net Change in Cash

GBPFY, 2002

Financial Leverage

1 x
Show all financial metrics

E-Therapeutics Operating Metrics

E-Therapeutics's Projects Launched was reported to be 12 in FY, 2016.
FY, 2015FY, 2016

Projects Launched

6 12
Show all operating metrics

E-Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

E-Therapeutics Online and Social Media Presence

Embed Graph

E-Therapeutics Frequently Asked Questions

  • When was E-Therapeutics founded?

    E-Therapeutics was founded in 2003.

  • Who are E-Therapeutics key executives?

    E-Therapeutics's key executives are Iain Ross, Jonny Wray and Ali Mortazavi.

  • How many employees does E-Therapeutics have?

    E-Therapeutics has 20 employees.

  • What is E-Therapeutics revenue?

    Latest E-Therapeutics annual revenue is £44 k.

  • What is E-Therapeutics revenue per employee?

    Latest E-Therapeutics revenue per employee is £2.2 k.

  • Who are E-Therapeutics competitors?

    Competitors of E-Therapeutics include IntelGenx, Mylan and Horizon Therapeutics.

  • Where is E-Therapeutics headquarters?

    E-Therapeutics headquarters is located at Blenheim Office Park, 17 Fenlock Rd, Long Hanborough.

  • Where are E-Therapeutics offices?

    E-Therapeutics has offices in Long Hanborough and Newcastle upon Tyne.

  • How many offices does E-Therapeutics have?

    E-Therapeutics has 2 offices.